Sort
130,381 grants matching “hiv”
ASSESSING ADM SERVICE NEEDS AMONG JUVENILE DETAINEES
$2,389,177Northwestern University · R01 · FY2000 · MH
Genetic Analysis of T-cell Differentiation
$2,388,750Remy Bosselut · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The Connie Wofsy Women's HIV Study
$2,388,720University Of California San Francisco · U01 · FY2003 · AI
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,388,013Michael R. Farzan · Scripps Florida · P01 · FY2013 · AI
IMPROVING AND EXPANDING ACCESS AND UPTAKE OF HIV TESTING AND COUNSELING (HTC) FOR
$2,387,654Kate Stratten · Intrahealth International, Inc. · U2G · FY2014 · GH
Units for HIV/AIDS Clinical Trials Networks
$2,387,394Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U01 · FY2008 · AI
Epitope-targeted Vaccines for HIV-1 Prevention
$2,386,714Xiangpeng Kong · New York University School Of Medicine · P01 · FY2012 · AI
Harnessing natural killer cell memory to fight viruses
$2,386,599Catherine A Blish · Stanford University · DP2 · FY2013 · AI
HPTN - CENTRAL LABORATORY
$2,386,540Johns Hopkins University · U01 · FY2001 · AI
Anti-viral immune responses in lymph node
$2,386,489Ulrich H Von Andrian · Harvard Medical School · P01 · FY2012 · AI
Alternative Formulations of Tenofovir and UC781
$2,386,283Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2010 · AI
PLANNING, IMPLEMENTATON, EVALUATION OF COMPREHENSIVE HIV PREVENTION (PEPFAR)
$2,386,280Harry Peter Hausler · Tb Hiv Care · U2G · FY2012 · GH
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,385,965Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Decision Making and HIV Risk: New Approaches to neuroAIDS Research in Drug Users
$2,385,000Christina S Meade · Duke University · DP2 · FY2015 · DA
Community-Based HIV VCT: South Africa
$2,384,355University Of California Los Angeles · U01 · FY2004 · MH
Administrative
$2,384,298King Kennard Holmes · University Of Washington · P30 · FY2013 · AI
GENERAL CLINICAL RESEARCH CENTER
$2,383,063University Of Texas Medical Br Galveston · M01 · FY2002 · RR
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)
$2,382,926Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2020 · HD
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,382,602Myron E Essex · Harvard School Of Public Health · UM1 · FY2014 · AI
Pitt-Ohio State Clinical Trials Unit
$2,382,302Sharon Riddler · University Of Pittsburgh At Pittsburgh · UM1 · FY2025 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$2,382,232Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development
$2,381,998Celia Labranche · Duke University · N01 · FY2021 · AI
Development of a Nanoemulsion Adjuvant: HIV elective project
$2,381,521Ali I. Fattom · Bluewillow Biologics, Inc. · N01 · FY2016 · AI
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,381,501Michael R. Farzan · Scripps Florida · P01 · FY2016 · AI
Project-002
$2,380,344Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA